Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity, Reactogenicity and Safety of the Trivalent Influvac 2012/2013 Vaccine
2012-001032-57Phase 3Completed
- Sponsor
- Abbott Laboratories
- Start
- Mar 2012
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of influenza vaccine in influenza, sponsored by Abbott Laboratories. Started Mar 2012; status: completed.
02
Drugs
influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on 2012-001032-57.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-001032-57.